Enfermedad Arterial Periférica (Claudicación, Investigacional)

Resumen para el Paciente

¿Está esto autorizado por FDA para este uso?

Not FDA-cleared for peripheral artery disease. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for PAD is highly investigational.

¿Qué evidencia existe?

Tier C (highly investigational). A handful of small uncontrolled case reports describe walking-distance improvement; there are no randomized controlled trials and no data on amputation, MI, or stroke prevention. Evidence-based PAD care per AHA/ACC 2016 guidelines includes smoking cessation, statin therapy, antiplatelet medication (aspirin or clopidogrel), structured supervised exercise (the strongest evidence for claudication), and revascularization (angioplasty / bypass) for lifestyle-limiting disease or critical limb ischemia. Leech therapy on a leg with poor arterial flow can cause tissue breakdown.

Riesgos principales

• Tissue breakdown, non-healing wound, or gangrene if applied to a limb with low ABI (under 0.6) — this is the dominant risk
• Bleeding from bite sites for 6 to 24 hours after detachment
• Local skin infection or, rarely, Aeromonas infection
• Worsening anemia from cumulative blood loss
• Allergic reaction to leech saliva (uncommon)
• Bleeding interaction with antiplatelet medications (aspirin, clopidogrel) — usually required for PAD
• Delay or replacement of evidence-based therapy with risk of amputation, MI, or stroke

Quién no debería considerar esto

• Patients with ABI under 0.6 (critical limb ischemia)
• Patients on antiplatelet therapy (aspirin, clopidogrel) — required for most PAD patients
• Patients with a diabetic foot ulcer or active gangrene
• Patients within 6 weeks of vascular intervention (angioplasty, stenting, bypass)
• Patients with rest pain or non-healing wounds (urgent vascular surgery indication)
• Patients with active infection, hemophilia, or severe anemia

Qué preguntar a su clínico

• What is my ankle-brachial index (ABI) and toe-brachial index, and what is my Rutherford / Fontaine class?
• Am I on a statin and appropriate antiplatelet therapy?
• Have I tried supervised exercise therapy — the highest-evidence intervention for claudication?
• Am I a candidate for revascularization (angioplasty, stent, bypass)?
• What is my vascular surgery team's opinion on adjunctive complementary therapy?
• If antiplatelet must continue, is leech therapy compatible at all?
• What is the practitioner's experience and Aeromonas-prevention plan?

Cuándo buscar atención urgente

• Sudden severe leg pain, coldness, pallor, or pulselessness (acute limb ischemia — call 911)
• Rest pain that interferes with sleep, or a non-healing leg or foot wound
• New gangrene, blackening, or ulceration
• Chest pain, pressure, or shortness of breath
• Sudden weakness, slurred speech, facial droop, or vision loss
• Bleeding from a bite site lasting more than 24 to 48 hours, fever, spreading redness, or pus
• Hives, throat tightness, or breathing difficulty